Bleron Baraliu is Founder and CEO at Ninety One. He has developed several AI models for analyzing and orthogonalizing big data sets, and is leading Ninety One’s charge toward digitization of healthcare and advancement of medicine toward personalized patient care. Bleron is a fanatic believer in fusing medical science with advanced models of data science and state-of-the-art technologies in order to lead the shift from allopathic, population based medicine to tailored patient care and AI-driven Precision Medicine. . Previously Bleron held senior executive positions at State Street, Barclays, and Citigroup, at one point managing an investment portfolio of over $1 Billion, earning him the distinction of Top 30 Traders Under 30 in the World by Trader Magazine in 2007. He is known in Wall Street for advancing technological innovation and driving responsible investing that is based on mathematical modelling and holistic analysis of large sets of data. Bleron earned a BA in Mathematics (with Honors) and a Masters in Mathematics of Finance, both from Columbia University in New York.